Kyverna Therapeutics Earnings & Forecasts

Kyverna Therapeutics (KYTX) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

会計四半期	報告日	実質EPS	推定EPS	驚き％
Q2	Aug 11, 2026	$-0.63	$-0.68	7.35 %
Q1	May 12, 2026	$-0.66	$-0.73	9.59 %
Q4	Mar 26, 2026	$-0.80	$-0.84	4.76 %
Q3	Nov 12, 2025	$-0.85	$-0.96	11.5 %

Quarterly Revenue (Billions)

Kyverna Therapeutics Guidance

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$-0.68	$-0.73	$-0.84	$-0.96
Actual	$-0.63	$-0.66	$-0.80	$-0.85
Surprise	+7.35%	+9.59%	+4.76%	+11.5%
Revenue
Estimate	—	—	—	—
Actual	$0	$0	$0	$0
Surprise	—	—	—	—

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$-0.69	$-0.78	$-0.78	$-0.78
Revenue
Consensus	—	—	—	—